Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

Chemoradiation for Advanced Laryngeal Cancer

진행성 후두암에서의 항암화학방사선 요법

  • Lee, Se-Hoon (Department of Internal Medicine, Seoul National University College of Medicine)
  • 이세훈 (서울대학교 의과대학 내과학교실)
  • Published : 2008.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685-1690 https://doi.org/10.1056/NEJM199106133242402
  2. Spaulding MB, Fischer SG, Wolf GT. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. J Clin Oncol. 1994;12(8):1592-1529 https://doi.org/10.1200/JCO.1994.12.8.1592
  3. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamouscell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355(9208):949-955 https://doi.org/10.1016/S0140-6736(00)90011-4
  4. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098 https://doi.org/10.1056/NEJMoa031317
  5. Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B, Trotti A, et al. Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx--Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. ASCO Meeting Abstracts. 2006;24: 5517
  6. Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol. 2006;24(4):593-598 https://doi.org/10.1200/JCO.2005.01.2047
  7. Worden FP, Wolf G, Eisbruch A, Lee J, Bradford CR, Chepeha D, et al. Chemo-selection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma. ASCO Meeting Abstracts. 2007;25:6005
  8. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17): 1695-1704 https://doi.org/10.1056/NEJMoa071028
  9. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007; 357(17):1705-1715 https://doi.org/10.1056/NEJMoa070956
  10. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567-578 https://doi.org/10.1056/NEJMoa053422